Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/9425
Title: Treatment of multiple chalazions with intralesional Kenalog-40 injections in juvenile patient: A case report
Authors: Janićijević-Petrović M.
Jancic, Snežana
Janicijevic, Katarina
Popovic A.
Issue Date: 2013
Abstract: Aim: To case report the efficacy of subcutaneous steroid injections in the treatment of multiple chalazions and to evaluate the safety of intralesional injection in primary and recurrent chalazions in juvenile patient. Case report: A 25-year-old man noticed lesions which appeared on upper lid during past three months. It was clinically presented with three focal, large and painful nodules in upper right eyelid. Inflammation process began on May the 1st of 2013. After one month in May 30th 2013 was directly administered synthetic steroid, Kenalog-40. Application of triamcinolone acetonide resulted in two satellite lesions, compared to the original, when the same incisions drained during the first surgery in July 5th 2013, with topical antibiotic-steroidal drugs and hot compresses. Second surgery was in July 26th 2013. Third surgery was performed in August 5st 2013 with second application of Kenalog-40. Combined treatment leads to recovery of clinical signs and inflammation of right upper eyelid with regressions of primary and recurrent chalazions. Conclusion: Two steroid subcutaneous injections produced complete resolution of multiple primary and recurrent chalazions. Clinical imperative was that recurrent or unusual refractory chalazions require referral to Hystopathological examination of curetting to exclude malignancy. © 2013 Janicijevic-Petrovic MA.
URI: https://scidar.kg.ac.rs/handle/123456789/9425
Type: article
DOI: 10.3889/MJMS.1857-5773.2013.0328
ISSN: 1857-5749
SCOPUS: 2-s2.0-84896710090
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

125

Downloads(s)

59

Files in This Item:
File Description SizeFormat 
10.3889-MJMS.1857-5773.2013.0328.pdf166 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons